Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial
Authors:
Open Access
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Clinical Nutrition
- Vol. 39 (2) , 388-394
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- Instituto de Salud Carlos III
This publication has 28 references indexed in Scilit:
- Glucose Variability is an Independent Predictor of Mortality in Hospitalized Patients Treated with Total Parenteral NutritionEndocrine Practice, 2014
- Parenteral Nutrition–Associated Hyperglycemia in Non–Critically Ill Inpatients Increases the Risk of In-Hospital Mortality (Multicenter Study)Diabetes Care, 2013
- Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2012
- Hypoglycemia-associated Mortality Is Not Drug-associated but Linked to ComorbiditiesThe American Journal of Medicine, 2011
- Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es StudyDiabetologia, 2011
- An Insulin Protocol for Management of Hyperglycemia in Patients Receiving Parenteral Nutrition Is Superior to Ad Hoc ManagementJournal of Parenteral and Enteral Nutrition, 2011
- 2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1C MeasurementDiabetes Care, 2010
- Hyperglycemia During Total Parenteral NutritionDiabetes Care, 2009
- American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic ControlDiabetes Care, 2009
- Evaluation of a Practical Technique for Determining Insulin Requirements in Diabetic Patients Receiving Total Parenteral NutritionJournal of Parenteral and Enteral Nutrition, 1993